According to the agreement, Surmodics made an upfront payment of $39.9m to Vetex.
Medical device and in vitro diagnostics company Surmodics has acquired Ireland-based medical device maker Vetex Medical to extend its thrombectomy portfolio.
Vetex Medical focuses on developing solutions for venous thromboembolism (VTE), or clot removal, to boost clinical outcomes and enhance patients’ quality of life.
According to the acquisition deal, Vetex received an upfront payment of $39.9m from Surmodics.